These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23145795)

  • 1. 5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity.
    Kranzler HR; Armeli S; Tennen H; Covault J
    Addict Biol; 2013 Nov; 18(6):1024-31. PubMed ID: 23145795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.
    Kranzler HR; Armeli S; Tennen H; Covault J; Feinn R; Arias AJ; Pettinati H; Oncken C
    J Clin Psychopharmacol; 2011 Feb; 31(1):22-30. PubMed ID: 21192139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.
    Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Vuittonet C; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1567-74. PubMed ID: 24773166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence.
    Kranzler HR; Armeli S; Tennen H
    Alcohol Clin Exp Res; 2012 Apr; 36(4):739-44. PubMed ID: 21981418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings.
    Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
    Alcohol; 2014 Sep; 48(6):515-22. PubMed ID: 25212749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
    Kenna GA; Zywiak WH; McGeary JE; Leggio L; McGeary C; Wang S; Grenga A; Swift RM
    Alcohol Clin Exp Res; 2009 Feb; 33(2):315-23. PubMed ID: 19032576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HTTLPR polymorphism of serotonin transporter and effects of sertraline in terminally ill cancer patients: report of eleven cases.
    Schillani G; Capozzo MA; Aguglia E; De Vanna M; Grassi L; Conte MA; Giraldi T
    Tumori; 2008; 94(4):563-7. PubMed ID: 18822694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment.
    Kranzler HR; Armeli S; Covault J; Tennen H
    Addict Biol; 2013 Jan; 18(1):193-201. PubMed ID: 22784013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of psychosocial adversity on alcohol intake in young adults: moderation by the LL genotype of the serotonin transporter polymorphism.
    Laucht M; Treutlein J; Schmid B; Blomeyer D; Becker K; Buchmann AF; Schmidt MH; Esser G; Jennen-Steinmetz C; Rietschel M; Zimmermann US; Banaschewski T
    Biol Psychiatry; 2009 Jul; 66(2):102-9. PubMed ID: 19358979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
    Johnson BA; Ait-Daoud N; Seneviratne C; Roache JD; Javors MA; Wang XQ; Liu L; Penberthy JK; DiClemente CC; Li MD
    Am J Psychiatry; 2011 Mar; 168(3):265-75. PubMed ID: 21247998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensity.
    Seneviratne C; Huang W; Ait-Daoud N; Li MD; Johnson BA
    Alcohol Clin Exp Res; 2009 Feb; 33(2):332-9. PubMed ID: 19032574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
    Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The moderating effect of FKBP5 and 5-HTTLPR polymorphisms on the day-level association between drinking to cope motivation and negative affect.
    Covault J; Armeli S; Tennen H
    Psychiatry Res; 2020 Feb; 284():112756. PubMed ID: 31931271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    J Affect Disord; 2016 May; 196():11-9. PubMed ID: 26896742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HTTLPR polymorphism moderates the effect of stressful life events on drinking behavior in college students of African descent.
    Kranzler HR; Scott D; Tennen H; Feinn R; Williams C; Armeli S; Taylor RE; Briggs-Gowan MJ; Covault J
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jul; 159B(5):484-90. PubMed ID: 22488930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of the 5-HTT gene-linked polymorphic region on emotional eating during stress exposure following tryptophan challenge.
    Markus CR; Verschoor E; Smeets T
    J Nutr Biochem; 2012 Apr; 23(4):410-6. PubMed ID: 21658929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter gene polymorphism (5-HTTLPR) and anxiety reactivity in daily life: a daily process approach to gene-environment interaction.
    Gunthert KC; Conner TS; Armeli S; Tennen H; Covault J; Kranzler HR
    Psychosom Med; 2007 Nov; 69(8):762-8. PubMed ID: 17942837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics.
    Herman AI; Conner TS; Anton RF; Gelernter J; Kranzler HR; Covault J
    Addict Biol; 2011 Jan; 16(1):124-32. PubMed ID: 20192950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of alcoholism subtypes as moderators of the response to sertraline treatment.
    Kranzler HR; Feinn R; Armeli S; Tennen H
    Alcohol Clin Exp Res; 2012 Mar; 36(3):509-16. PubMed ID: 21895712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
    Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
    Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.